|
Brief Reports
Citations 311-320 of 1234 total displayed.
|
Past content
(since Jul 1999):
|
Expression of oncogenic K-ras from its endogenous promoter leads to a partial block of erythroid differentiation and hyperactivation of cytokine-dependent signaling pathways
- Jing Zhang, Yangang Liu, Caroline Beard, David A. Tuveson, Rudolf Jaenisch, Tyler E. Jacks, and Harvey F. Lodish
Blood 2007; 109: 5238-5241.
[Abstract]
[Full text]
[PDF]
A novel proteoliposomal vaccine elicits potent antitumor immunity in mice
- Mircea C. Popescu, Richard J. Robb, Michael M. Batenjany, Lawrence T. Boni, Mary E. Neville, Robin W. Pennington, Sattva S. Neelapu, and Larry W. Kwak
Blood 2007; 109: 5407-5410.
[Abstract]
[Full text]
[PDF]
ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia
- Chiara Gregorj, Maria R. Ricciardi, Maria T. Petrucci, Maria C. Scerpa, Fabiana De Cave, Paola Fazi, Marco Vignetti, Antonella Vitale, Marco Mancini, Giuseppe Cimino, Salvatore Palmieri, Francesco Di Raimondo, Giorgina Specchia, Francesco Fabbiano, Nicola Cantore, Federico Mosna, Andrea Camera, Mario Luppi, Luciana Annino, Eustachio Miraglia, Giuseppe Fioritoni, Francesca Ronco, Giovanna Meloni, Franco Mandelli, Michael Andreeff, Michele Milella, Robin Foà, and Agostino Tafuri, the GIMEMA Acute Leukemia Working Party, Italy
Blood 2007; 109: 5473-5476.
[Abstract]
[Full text]
[PDF]
A complex splicing defect associated with homozygous ankyrin-deficient hereditary spherocytosis
- E. Jennifer Edelman, Yelena Maksimova, Feride Duru, Cigdem Altay, and Patrick G. Gallagher
Blood 2007; 109: 5491-5493.
[Abstract]
[Full text]
[PDF]
Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist
- Julian M. Jenkins, Daphne Williams, Yanli Deng, Joanne Uhl, Valerie Kitchen, David Collins, and Connie L. Erickson-Miller
Blood 2007; 109: 4739-4741.
[Abstract]
[Full text]
[PDF]
Platelet-bound lipopolysaccharide enhances Fc receptor–mediated phagocytosis of IgG-opsonized platelets
- John W. Semple, Rukhsana Aslam, Michael Kim, Edwin R. Speck, and John Freedman
Blood 2007; 109: 4803-4805.
[Abstract]
[Full text]
[PDF]
The novel inhibitory receptor G6B is expressed on the surface of platelets and attenuates platelet function in vitro
- Stephen A. Newland, Iain C. Macaulay, Andres R. Floto, Edwin C. de Vet, Willem H. Ouwehand, Nicholas A. Watkins, Paul A. Lyons, and Duncan R. Campbell
Blood 2007; 109: 4806-4809.
[Abstract]
[Full text]
[PDF]
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT
- Jeffery S. Miller, Sarah Cooley, Peter Parham, Sherif S. Farag, Michael R. Verneris, Karina L. McQueen, Lisbeth A. Guethlein, Elizabeth A. Trachtenberg, Michael Haagenson, Mary M. Horowitz, John P. Klein, and Daniel J. Weisdorf
Blood 2007; 109: 5058-5061.
[Abstract]
[Full text]
[PDF]
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511
- Meir Wetzler, Ben L. Sanford, Joanne Kurtzberg, Divino DeOliveira, Stanley R. Frankel, Bayard L. Powell, Jonathan E. Kolitz, Clara D. Bloomfield, and Richard A. Larson
Blood 2007; 109: 4164-4167.
[Abstract]
[Full text]
[PDF]
CD33 expression and P-glycoprotein–mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy
- Roland B. Walter, Ted A. Gooley, Vincent H. J. van der Velden, Michael R. Loken, Jacques J. M. van Dongen, David A. Flowers, Irwin D. Bernstein, and Frederick R. Appelbaum
Blood 2007; 109: 4168-4170.
[Abstract]
[Full text]
[PDF]
|
|
